GNI Group Acquires Ayumi Pharmaceutical For JPY 44.8 Billion (About $276 Million)
By Amit Chowdhry ● Jul 5, 2026
GNI Group announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings from shareholders led by Blackstone. The deal had an enterprise value of about JPY 44.8 billion (about $276 million). GNI Group completed the settlement through a combination of cash and the issuance of new shares, and the company will welcome Blackstone, Toho Holdings, and Hisamitsu Pharmaceutical as new shareholders.